Isolated splenic metastasis from rectal carcinoma: A rare occurrence

Sarika Jain, Sumeet Munjal, Rhonda K. Yantiss, Toyooki Sonoda, Thomas J. Fahey, Joseph T. Ruggiero, Alok Anand, Adam Gersten, Stanley J. Goldsmith, Allyson J. Ocean*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


The presence of isolated splenic metastasis in rectal carcinoma is uncommon and usually presents as an asymptomatic mass, noted incidentally on imaging. Splenectomy is usually performed with the goal of curing metastatic disease. It is unclear if adjuvant chemotherapy affords any benefit, and the prognosis is unknown. The case of a young woman is reported, in whom an isolated metastatic lesion in the spleen was discovered 9 months after adjuvant chemotherapy for stage III rectal adenocarcinoma. The patient has remained disease-free for nearly 5 years following splenectomy and chemotherapy. To our knowledge, this is the fourth reported case in the English literature of an isolated splenic metastatic lesion from rectal cancer. We discuss the unique presentation, the importance of post-treatment surveillance, and the implementation of multi-modality treatment strategies in this young patient.

Original languageEnglish (US)
Pages (from-to)499-504
Number of pages6
JournalCase Reports in Oncology
Issue number3
StatePublished - Sep 2011


  • Chemotherapy
  • Solitary splenic metastasis
  • Splenectomy
  • Surveillance

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Isolated splenic metastasis from rectal carcinoma: A rare occurrence'. Together they form a unique fingerprint.

Cite this